Repertoire Immune Medicines - Crunchbase Company Profile & Funding

Q: Who invested in Repertoire Immune Medicines?

Repertoire Immune Medicines has 6 investors including Invus And PSP Investments.

Q: How much funding has Repertoire Immune Medicines raised to date?

Repertoire Immune Medicines has raised obfuscated.

Overview

Repertoire Immune Medicines

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Repertoire Immune Medicines

CB Rank

16571

Repertoire Immune Medicines is a clinical stage biotechnology company.

Founded

obfuscation

Private

Series B

Cambridge, Massachusetts, United States

51-100

www.repertoire.com

Biotechnology

Life Science

Medical

Therapeutics

Funding Rounds

Series B

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Lucia Celona: EVP, Chief Human Resources Officer
Anthony Coyle: President, Research and Development
Past Role: Pandion Therapeutics, CEO and Founder

Details

Legal Name

Torque Therapeutics, Inc.

Also Known As

Torquetx

Operating Status

Active

Company Type

For Profit

Founders

Bart Henderson, Ewen Cameron, Noubar Afeyan, Thomas Lars Andresen, Ulrik Nielsen

About the Company

Repertoire Immune Medicines is a clinical stage biotechnology company working to unleash the human immune system to prevent, treat or cure cancer, autoimmune conditions and infectious diseases. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.

Phone Number

(617) 863-3650

Predictions & Insights

Growth Insight

See this Growth Insight

Repertoire Immune Medicines is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

DECODE Platform

A platform that decodes the immune synapse by identifying T cell receptors and disease-relevant epitopes across all human HLA molecules to characterize cellular immune responses in diseases.

RPTR-1-201

A T-cell receptor bispecific development candidate targeting a novel peptide presented on multiple solid tumors, designed for clinical development in cancer treatment.

Research & Development

Repertoire Immune Medicines is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Repertoire Immune Medicines	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Repertoire Immune Medicines	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Repertoire Immune Medicines	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Repertoire Immune Medicines	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Repertoire Immune Medicines	5	obfuscated obfuscation	—	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Repertoire Immune Medicines	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Repertoire Immune Medicines	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Repertoire Immune Medicines	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Repertoire Immune Medicines	5	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Repertoire Immune Medicines	5	obfuscated obfuscation	—	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Invus	—	Series B - Repertoire Immune Medicines	—
Invus	—	Series B - Repertoire Immune Medicines	—
Invus	—	Series B - Repertoire Immune Medicines	—
Invus	—	Series B - Repertoire Immune Medicines	—
Invus	—	Series B - Repertoire Immune Medicines	—